Labshake search
Citations for Tocris :
351 - 400 of 1546 citations for 7 Chloro 1 2 3 4 tetrahydroisoquinoline since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: Pancreatitis was induced by 7 intraperitoneal injections of cerulein (50 μg/kg; Tocris Bioscience, cat#62-641) at hourly intervals on two alternating days ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Cell Biology 2020Quote: ... 2.5 mg/kg BW for 4,4’,4’’-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT, Tocris), 5 mg/kg BW for 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN ...
-
bioRxiv - Neuroscience 2021Quote: ... exendin 4 (10 μg/kg, Tocris), leptin (twice/day for 2 days at 0.25 mg/kg ...
-
bioRxiv - Immunology 2020Quote: ... and 4-Octyl-Itaconate (Tocris Bioscience) (100uM ...
-
bioRxiv - Neuroscience 2021Quote: ... 4-AP (100 μM, Tocris Bioscience), and GBZ (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... MNI Caged Glu (Tocris, 4 mM), APV (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... 4 mM MNI-caged glutamate (Tocris) and 1 μM tetrodotoxin (TTX ...
-
bioRxiv - Immunology 2021Quote: ... 100 nM Z-4-hydroxytamoxifen (Tocris), and either puromycin (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2020Quote: 4-PBA (200mg/kg; Tocris, 2682) was completely dissolved in 1X sterile PBS and injected intraperitoneally (n=6 ...
-
bioRxiv - Neuroscience 2023Quote: ... and Carbamazepine (Tocris, #298-46-4). The working dilution was first diluted into the medium before regular medium change ...
-
bioRxiv - Immunology 2022Quote: ... 2-aminoethoxydiphenyl borate (2-APB) or trans-Ned-19 (all Tocris).
-
bioRxiv - Animal Behavior and Cognition 2022Quote: ... (R)-(+)-WIN 55,212-2) WIN 55,212-2 was purchased from Tocris Cookson Ltd ...
-
bioRxiv - Biochemistry 2023Quote: ... 5% CO2 with either DMSO or MLi-2 (Tocris; 2 μM) for 1 hour ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 µM CHIR99021 (Tocris 4423, or Axon 1386); 4 µM TCS JNK 60 (Tocris 3222) ...
-
bioRxiv - Neuroscience 2019Quote: ... 3-dione (CNQX, Tocris, 50 μM final concentration). CNQX and DQNX were assumed to act equally ...
-
bioRxiv - Neuroscience 2020Quote: ... In all cases 3 mg/ml biocytin (Tocris) was added in the recording solution and no extra pharmacology was added ...
-
bioRxiv - Cell Biology 2021Quote: ... p38 MAPK inhibitor SB203580 (3 uM, Tocris, #1202), JNK inhibitor SP600125 (20uM ...
-
bioRxiv - Neuroscience 2022Quote: ... GABA (500 µL, 3 mM, Tocris Bioscience, 0344), CaCl2 (370 µL ...
-
Reduced Hippocampal Inhibition and Enhanced Autism-Epilepsy Comorbidity in Mice Lacking Neuropilin 2bioRxiv - Neuroscience 2021Quote: ... kynurenic acid (3 mM KyA, Tocris, Ellisville, MO) in the recording aCSF ...
-
bioRxiv - Bioengineering 2022Quote: ... 3 μM CHIR99021 (Tocris Bioscience, catalogue no. 4423), 50 nM PI-103 (Tocris Bioscience ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 mM GSK3 inhibitor CHIR99021 (4953/50 Tocris), and 1,000 U/ml LIF (ESGRO ESG1107 ...
-
bioRxiv - Neuroscience 2021Quote: ... In some cases 3 mg/ml biocytin (Tocris) was added in the recording solution ...
-
bioRxiv - Neuroscience 2022Quote: ... 3) a selective PIEZO1 agonist Yoda1 (5586, Tocris). For pressure pulse stimulation ...
-
bioRxiv - Developmental Biology 2023Quote: ... N2B27 was supplemented with 3 µM CHIR99021 (Tocris), 1 µM PD0325901 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 mM L-glutamate (Glu, #0218, Tocris, UK) and 0.1 mM cyclothiazide (CTZ ...
-
bioRxiv - Bioengineering 2023Quote: ... which included 3 µM CHIR 99021 (Tocris, 4423) +/- 10 µM Y27632 (StemCell Technologies ...
-
bioRxiv - Immunology 2021Quote: In vitro tamoxifen was given as 4-hydroxytamoxifen (4-OH-Tamoxifen or OHT) (TOCRIS, Cat no. 3412) solubilized in DMSO (Life Technologies ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of a-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2019Quote: ... Eye movements were prevented by injection of a-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye ...
-
bioRxiv - Neuroscience 2020Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Biochemistry 2021Quote: ... cells were treated with either DMSO or 1 µM of LRRK2 kinase inhibitor (MLi-2, cat.no. 5756, TOCRIS) for 90 mins and then examined for localization ...
-
bioRxiv - Systems Biology 2019Quote: ... 2μM IWP-2 (Tocris) and 10μM DAPT [goblet and enteroendocrine cells] (25).
-
bioRxiv - Neuroscience 2021Quote: ... MLi-2 (Tocris #5756) was reconstituted in DMSO to a stock concentration of 10mM ...
-
bioRxiv - Neuroscience 2022Quote: ... WIN55,212-2 (1038, Tocris), and Torin 2 (4248 ...
-
bioRxiv - Cell Biology 2020Quote: ... MLi-2 (Tocris, 5756) was used at 1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: WIN55,212-2 (Tocris, #1038), α-Humulene (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin-2 (Tocris 4248), rapamycin (CalBiochem 553211) ...
-
bioRxiv - Cell Biology 2019Quote: ... and IWP-2 (Tocris) were added at 3µM and 1µM ...
-
bioRxiv - Cell Biology 2023Quote: ... 2 µM Dorsomorphin (TOCRIS) and 2 µM XAV939 (Stemgent) ...